AutismInsights
Back to research database
Emerging

Comment on "Impact of AOC1 and HNMT Variants on the Therapeutic Outcomes of a Histamine Reducing Diet in Autism Spectrum Disorder".

Journal of molecular neuroscience : MN2025

Raza Rafia, Khan Arooba

What this study means for families

This article critiques a study about special diets for autistic children. The original study looked at removing high-histamine foods, but also removed gluten, dairy, and sugar at the same time. The critics say this makes it impossible to know which dietary changes actually helped. They also point out the study had very small numbers of children and didn't clearly explain the results. The authors suggest better research is needed.

Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.

Research summary

This is a commentary critiquing a recent study on histamine-reducing diets for children with autism spectrum disorder. The authors identify several methodological concerns with the original research, including the use of a broad elimination diet that removed multiple food components beyond histamine, making it impossible to isolate histamine's specific effects. Other limitations highlighted include unexplained participant selection criteria, very small sample sizes for genetic analyses (sometimes single participants), lack of post-intervention histamine measurements, and unclear clinical significance of outcomes. The commentary calls for more rigorous research with controlled diets, standardized methods, larger samples, and clinically meaningful outcomes.

Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.

Key findings

  • 1

    Original study used broad elimination diet removing histamine, gluten, dairy, sugar and other foods simultaneously

    Confidence: highRelevance: Makes it impossible to determine if histamine reduction specifically caused reported improvements
  • 2

    Genetic analyses in original study based on very small sample sizes, sometimes single participants

    Confidence: highRelevance: Reduces reliability and generalizability of genetic variant findings
  • 3

    Original study lacked post-intervention histamine measurements and clear clinical significance of outcomes

    Confidence: highRelevance: Prevents verification of dietary compliance and assessment of real-world impact

Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.

Clinical implications

Current evidence for histamine-reducing diets in autism is insufficient due to methodological limitations. Clinicians should be cautious about recommending such restrictive diets without stronger evidence. Future research should use controlled methodologies, larger samples, and measure clinically relevant outcomes to establish whether histamine reduction specifically benefits autistic individuals.

Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.

Limitations

This is a commentary, not original research. The limitations discussed pertain to the critiqued study rather than new data. The commentary does not provide alternative evidence or conduct independent analysis of histamine-reducing diets in autism.

Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.

Original abstract

Kadiyska et al. recently investigated the impact of a histamine-reducing diet in children with autism spectrum disorder (ASD), with attention to potential modifying effects of AOC1 and HNMT gene variants. Although the study poses an important question, several design limitations may affect the certainty of its conclusions. The dietary intervention removed not only foods high in histamine but also gluten, dairy, sugar, and other items. Such broad restrictions can influence health and behavior on their own.

This makes it difficult to determine whether the reported improvements were specifically the result of reduced histamine. The histamine cut-off chosen for participant selection was not explained or tied to clinical standards, which makes reproducibility less clear. In addition, some of the genetic results rested on very small numbers, at times a single child, reducing confidence in their reliability. Finally, histamine levels were not re-measured after the intervention, and the developmental outcomes were not fully explained in terms of clinical significance.

Stronger evidence will require controlled diets, standardized thresholds, larger cohorts, and outcomes relevant to daily life.

View Original Paper

View original paperFull paper via publisher (may require subscription)

Evidence Grade

Emerging

emerging

Grade assigned by AutismInsights based on study type and published abstract.

Study Details

Journal
Journal of molecular neuroscience : MN
Year
2025
PMID
41021140
DOI
10.1007/s12031-025-02422-8

MeSH Terms

HumansAutism Spectrum DisorderHistamineHistamine N-MethyltransferaseChild